ITCI
Jennison Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,212
| Closed | -$637K | – | 616 |
|
|
2024
Q1 | $637K | Buy |
+9,212
| New | +$637K | ﹤0.01% | 542 |
|
|
2023
Q4 | – | Sell |
-186,867
| Closed | -$9.73M | – | 629 |
|
|
2023
Q3 | $9.73M | Buy |
186,867
+24,094
| +15% | +$1.26M | 0.01% | 367 |
|
|
2023
Q2 | $10.3M | Buy |
162,773
+150,480
| +1,224% | +$9.53M | 0.01% | 375 |
|
|
2023
Q1 | $666K | Sell |
12,293
-3,761
| -23% | -$204K | ﹤0.01% | 546 |
|
|
2022
Q4 | $850K | Sell |
16,054
-1,251
| -7% | -$66.2K | ﹤0.01% | 512 |
|
|
2022
Q3 | $805K | Buy |
17,305
+4,154
| +32% | +$193K | ﹤0.01% | 527 |
|
|
2022
Q2 | $751K | Buy |
+13,151
| New | +$751K | ﹤0.01% | 551 |
|
|
2017
Q1 | – | Sell |
-1,024,366
| Closed | -$15.5M | – | 803 |
|
|
2016
Q4 | $15.5M | Sell |
1,024,366
-289,150
| -22% | -$4.36M | 0.02% | 439 |
|
|
2016
Q3 | $20M | Buy |
1,313,516
+33,919
| +3% | +$517K | 0.02% | 409 |
|
|
2016
Q2 | $49.7M | Buy |
1,279,597
+1,987
| +0.2% | +$77.1K | 0.05% | 286 |
|
|
2016
Q1 | $35.5M | Buy |
1,277,610
+19,764
| +2% | +$549K | 0.04% | 337 |
|
|
2015
Q4 | $67.7M | Buy |
1,257,846
+855,846
| +213% | +$46M | 0.07% | 236 |
|
|
2015
Q3 | $16.1M | Buy |
+402,000
| New | +$16.1M | 0.02% | 457 |
|